Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death

BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are being wildly used as target therapy in non-small-cell lung cancer (NSCLC). However, NSCLC patients with wild-type EGFR and KRAS mutation are primary resistant to EGFR-TKIs such as gefitinib. Curcumin has been k...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ping, Huang, Han-Peng, Wang, Yi, Jin, Jun, Long, Wei-Guo, Chen, Kan, Zhao, Xiao-Hui, Chen, Chen-Guo, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567416/
https://www.ncbi.nlm.nih.gov/pubmed/31196210
http://dx.doi.org/10.1186/s13046-019-1234-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567416/
https://www.ncbi.nlm.nih.gov/pubmed/31196210
http://dx.doi.org/10.1186/s13046-019-1234-8

Ejemplares similares